Cyberounds Logo
July 29, 2010 | LOGIN | REGISTER | HELP | 


email a friend print Bookmark and Share
Optimal Treatment for Atrial Fibrillation
CME credit is no longer available for this conference.
Anne Hamilton Dougherty, M.D.

Dr. Dougherty is an Associate Professor from the Electrophysiology Laboratory, Division of Cardiology, Department of Internal Medicine, University of Texas - Houston.

Dr. Dougherty reports no commercial conflict of interest.

This activity is made possible by an unrestricted educational grant from the Novartis Foundation for Gerontology.


Release Date: 06/01/1998
Termination Date: 06/01/2001

Estimated time to complete: 1 hour(s).

Albert Einstein College of Medicine designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Albert Einstein College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
 
Learning Objectives
Upon completion of this Cyberounds®, the participant should be able to:
  • Review the epidemiology of atrial fibrillation, its complications and their prevention
  • Discuss the merits and limitations of antiarrhythmic drugs in converting and preventing atrial fibrillation
  • Discuss non-pharmacological strategies for managing atrial fibrillation.

 
This conference may include discussion of commercial products and services.

The opinions expressed herein are those of the authors and do not necessarily represent the views of the sponsor or its publisher. Please review complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.
 
Please click below to accept the terms of this CME activity